As a global leader in medical diagnostics, Abbott understood
from the start that COVID-19 would require a major mobilization
on our part. We quickly formed multiple research and
development teams, who worked in parallel, to create a range
of tools to detect the virus and its antibodies at every stage
of infection.
environment that fosters innovation and job
satisfaction. This year we saw a 24 percent
increase in the overall size of our workforce,
whilst also maintaining a higher female to male
ratio with 54 percent of the global workforces
comprising women.